COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Two UC San Diego Physician-Scientists Named to Association of American Physicians

 

May 07, 2007  |  

The Association of American Physicians (AAP) has elected two physician-scientists from the University of California, San Diego School of Medicine faculty as new members: Patricia Finn, MD, PhD, Chief of Pulmonary and Critical Care Medicine and Anthony Wynshaw-Boris, MD, PhD, Director, Center for Human Genetics and Genomics Chief, Division of Genetics, Department of Pediatrics.

The Association of American Physicians is a nonprofit, professional organization founded for "the advancement of scientific and practical medicine."  Today, the Association is composed of about 1,000 active members and approximately 550 emeritus and honorary members from the United States, Canada and other countries.

Each year, the Council of the Association elects 60 new members.  This year, 67 inductees were announced at the AAP national meeting in April.

Finn was recognized for her pioneering research regarding the mechanisms behind the development of asthma and other inflammatory lung diseases.  Finn is especially interested in understanding how asthma develops early in life and discovering new ways to prevent and treat asthma and other related diseases.

Wynshaw-Boris’ focus is on the genetic manipulation of mice to generate a number of mouse models which replicate human diseases.  He has used the insights obtained from these animals to define novel pathways for disease pathogenesis and therapeutics. 

# # #

Media Contact:  Kim Edwards,  619-543-6163,

kedwards@ucsd.edu




Media Contact

Share This Article


Related News

7/1/2022
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
6/29/2022
UC San Diego Health study identifies the main job stressors contributing to physician suicides.
6/21/2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
6/15/2022
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.



Follow Us